Stellanin: a promising medical drug for accompanying therapy in lung cancer treatment
Автор: Elena M. Frantsiyants, Irina V. Kaplieva, Valerija A. Bandovkina, Lidia K. Trepitaki, Ekaterina I. Surikova, Irina V. Neskubina, Julija A. Pogorelova, Natalia D. Cheryarina, Alla I. Shikhlyarova, Dmitriy A. Kharagezov, Stanislav G. Vlasov, Roza G. Luganskaya, Ekaterina S. Bosenko
Журнал: Cardiometry @cardiometry
Рубрика: Original research
Статья в выпуске: 20, 2021 года.
Бесплатный доступ
One of the cancer prevention measures involves the correction of the altered functions of the body’s regulatory systems. Many malignant tumors are accompanied by the thyroid system dysfunction. The aim of our study was to reveal an effect of an iodine-containing drug on the development of a tumor process in the lungs and the level of thyroid hormones in blood and the thyroid gland in male rats. Material and methods. Outbred white male rats were divided into the following groups: a group of intact animals (n=7); a comparison group – 5 weeks after an intravenous inoculation of sarcoma 45 (S45) at 2*106 (n=7); a main group – 5 weeks after an intravenous inoculation of S45 and intragastric administration of Stellanin at a single dose of 0.4 mg/kg within an hour after the inoculation (n=10). RIA was used to determine levels of free (F) and total triiodothyronine (T3) and thyroxine (T4) in the blood serum and the thyroid. Results. The lungs of rats in the comparison group were totally affected by the tumor, and the thyroid gland showed a sharp decrease in the levels of all hormone forms: T4 – by 18.7 times, T3 – by 8.5 times, FТ4 – by 8.1 times, FТ3 – by 21.3 times, while only FТ4 and FТ3 decreased in blood by 2.5 and 1.5 times, respectively (p<0.05). No tumor lesions were detected in the lungs of rats of the main group, and the hormone levels exceeded the levels in the comparison group: in the thyroid, FT4 by 3.7, T4 by 15.0 and T3 by 6.0 times; in blood, FT4 by 3.3 and FT3 by 1.7 times Conclusions. The effect of Stellanin inhibiting malignant growth of S45 in the lungs is accompanied by the restoration of low levels of thyroid hormones in the thyroid and blood.
Pliss lymphosarcoma, Thyroid gland, Thyroid hormones, Rats, Stellanin drug
Короткий адрес: https://sciup.org/148322430
IDR: 148322430 | DOI: 10.18137/cardiometry.2021.20.3439
Список литературы Stellanin: a promising medical drug for accompanying therapy in lung cancer treatment
- Bray F, Jacques F, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018; (68): 394–424. doi:10.3322/caac.21492
- DiMarco-Crook C, Xiao H. Diet-based strategies for cancer chemoprevention: The role of combination regimens using dietary bioactive components. Annu. Rev. Food Sci. Technol. 2015;6: 505–26. doi: 10.1146/annurev-food-081114-110833
- Kit OI, et al. Activation therapy: theoretical and applied aspects. Cardiometry. 2015;7: 22-9.
- Kit OI, et al. The development of post-castration syndrome and the corrective effect of xenon in an exponential dose regime in young patients with oncopathology of the reproductive organs. South-Russian journal of oncology. 2020;1(3): 6-17. [in Russian]
- Kozlova MB, et al. The state of systemic hormonal homeostasis in rats with s-45 sarcoma cells transplanted nto the lung Basic research. 2015;1(8): 1605-10. [in Russian]
- Puhr HC, et al. Elevated Free Thyroxine Levels Are Associated with Poorer Overall Survival in Patients with Gastroesophageal Cancer: A Retrospective Single Center Analysis. Horm Cancer. 2020; 11(1): 42-51. doi: 10.1007/s12672-019-00374-1.
- Aceves C., Anguiano B., Delgado G. The extrathyronine actions of iodine as antioxidant, apoptotic, and differentiation factor in various tissues Thyroid. 2013 23(8): 938–46. doi: 10.1089/thy.2012.0579.
- Gerasimova GK, Zhukova OS, Fetisova LV, Baryshnikov AYu, Solodunov YuYu, Stradomsky BV. Cytotoxic activity of the stellanin preparation on human tumor cells in vitro. Russian Biotherapeutic Journal. 2013; 12(4): 51-4. [in Russian]
- Gerasimova GK, Markova NP, Golubeva IS, Apryshko GN, Solodunov YuYu., Stradomsky BV. Antitumor activity of the stellanin preparation on transplanted tumors of mice. Russian Biotherapeutic Journal. 2014; 13(1): 43-8. [in Russian]
- Kit OI, Frantsyants E.M., Kaplieva I.V., Trepitaki L.K., Stradomsky B.V. RF patent No. 2546034C1 dated 04/10/2015. Bul. No. 10, 6 p. [in Russian]
- Sidorenko YuS, Frantsiyants EM, Tkalya LD. 2388064 RF. Bull. 2010 No. 12. [in Russian]
- Huang J, et al. Implication from thyroid function decreasing during chemotherapy in breast cancer patients: chemosensitization role of triiodothyronine. BMC Cancer. 2013; 6(13): 313-34. doi: 10.1186/1471-2407-13-334.
- Yasar ZA, Kirakli C, Yilmaz U, Ucar ZZ, Talay F. Can non-thyroid illness syndrome predict mortality in lung cancer patients? A prospective cohort study. Horm Cancer. 2014; 5(4): 240-6. doi: 10.1007/s12672-014-0183-0.
- Lin L, Ren L, Wen L, Wang Y, Qi J. Effect of evodiamine on the proliferation and apoptosis of A549 human lung cancer cells. Mol. Med. Rep. 2016; 14: 2832–8. doi: 10.3892/mmr.2016.5575.
- Latteyer S., et al. Thyroxine promotes lung cancer growth in an orthotopic mouse model. Endocr Relat Cancer. 2019; 26(6): 565-74. doi: 10.1530/ERC-18-0353. PMID: 30893642.
- Susarla R, Watkinson JC, Eggo MC. Regulation of human thyroid follicular cell function by inhibition of vascular endothelial growth factor receptor signaling. Mol Cell Endocrinol. 2012; 351(2): 199-207. doi:10/1016/j.mce.2011.12.009.
- Dvadnenko KV, Vodolazhsky DI, Stradomsky BV. Effect of 1,3-diethylbenzimidazolium iodide on the ultrastructure of mitochondria in Hep2 cells. Actual problems of biology, nanotechnology and medicine. Materials of the 4th International Scientific and Practical Conference. Rostov-on-Don, 2011: 17-8 (abstr). [in Russian]
